Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex32x2.htm |
| EX-32.1 - EX-32.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex32x1.htm |
| EX-31.2 - EX-31.2 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex31x2.htm |
| EX-31.1 - EX-31.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex31x1.htm |
| EX-21.1 - EX-21.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex21x1.htm |
| EX-14.1 - EX-14.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex14x1.htm |
| EX-10.30 - EX-10.30 - CROSS COUNTRY HEALTHCARE INC | ccrn20201231-10kex10x30.htm |
| EX-10.29 - EX-10.29 - CROSS COUNTRY HEALTHCARE INC | ccrn20201221-10kex10x29.htm |
| 10-K - 10-K - CROSS COUNTRY HEALTHCARE INC | ccrn-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-145484, 333-188519, 333-196639, 333-218557 and 333-238719 on Form S-8 of our report dated February 25, 2021, relating to the consolidated financial statements of Cross Country Healthcare, Inc. and subsidiaries, and the effectiveness of Cross Country Healthcare, Inc. and subsidiaries’ internal control over financial reporting, appearing in this Annual Report on Form 10-K of Cross Country Healthcare, Inc. for the year ended December 31, 2020.
| /s/ Deloitte & Touche LLP | ||
Boca Raton, Florida
February 25, 2021